Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Inhibition of Multiple Myeloma Cell Proliferation and Increase of Apoptosis through Regulation of the NF-κB and JNK Pathways by Silencing TRAF6 C-Domain mRNA.

Haiming Chen, MD, PhD, Richard A. Campbell, BS, Daocheng Zhu, MD, PhD, Sonia Guangxu Li, BS, Christine Pan James, BA, Janice Santos, BS, MS, Cathy S. Wang, BS, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2004) 104 (11): 3355.

https://doi.org/10.1182/blood.V104.11.3355.3355

Published: 2004

Journal Articles

Pleitrophin Is Highly Expressed by Myeloma Cells, Elevated in the Serum of Myeloma Patients, and Is a New Autocrine Growth Factor for This B Cell Malignancy.

Haiming Chen, MD, PhD, Daocheng Zhu, MD, PhD, Richard A. Campbell, BS, Christine Pan James, BA, Sonia Guangxu Li, BS, Janice Santos, BS, MS, Cathy S. Wang, BS, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2004) 104 (11): 3349.

https://doi.org/10.1182/blood.V104.11.3349.3349

Published: 2004

Journal Articles

Arsenic Trioxide Shows Synergistic Anti-Myeloma Effects When Combined with Bortezomib and Melphalan In Vitro and Helps Overcome Resistance of Multiple Myeloma Cells to These Treatments in Vivo.

Richard A. Campbell, BS, Haiming Chen, MD, PhD, Daocheng Zhu, MD, PhD, Janice C. Santos, BS, MS, Benjamin Bonavida, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2004) 104 (11): 2467.

https://doi.org/10.1182/blood.V104.11.2467.2467

Published: 2004

Journal Articles

Ascorbic Acid Overcomes Drug Resistance in Myeloma and Significantly Increases the Anti-Myeloma Effects of both Arsenic Trioxide and Melphalan in Vitro and in Vivo.

Richard A. Campbell, BS, Haiming Chen, MD, PhD, Daocheng Zhu, MD, PhD, Janice C. Santos, BS, MS, Benjamin Bonavida, PhD, Shen Pang, PhD, Jonathan Said, MD, James R. Berenson, MD

Blood (2004) 104 (11): 2470.

https://doi.org/10.1182/blood.V104.11.2470.2470

Published: 2004

Journal Articles

Pleitrophin Alone Induces Transdifferentiation of Human Monocytes and Bone Marrow Stem Cells into Endothelial Cells.

Haiming Chen, MD, PhD, Daocheng Zhu, MD, PhD, Richard A. Campbell, BS, Christine Pan James, BA, Cathy S. Wang, BS, Janice Santos, BS, MS, Benjamin Bonavida, Phd, James R. Berenson, MD

Blood (2004) 104 (11): 1472.

https://doi.org/10.1182/blood.V104.11.1472.1472

Published: 2004

NARROW

Inhibition of Multiple Myeloma Cell Proliferation and Increase of Apoptosis through Regulation of the NF-κB and JNK Pathways by Silencing TRAF6 C-Domain mRNA.

Pleitrophin Is Highly Expressed by Myeloma Cells, Elevated in the Serum of Myeloma Patients, and Is a New Autocrine Growth Factor for This B Cell Malignancy.

Arsenic Trioxide Shows Synergistic Anti-Myeloma Effects When Combined with Bortezomib and Melphalan In Vitro and Helps Overcome Resistance of Multiple Myeloma Cells to These Treatments in Vivo.

Ascorbic Acid Overcomes Drug Resistance in Myeloma and Significantly Increases the Anti-Myeloma Effects of both Arsenic Trioxide and Melphalan in Vitro and in Vivo.

Pleitrophin Alone Induces Transdifferentiation of Human Monocytes and Bone Marrow Stem Cells into Endothelial Cells.

Email alerts

ASH Publications

American Society of Hematology

Inhibition of Multiple Myeloma Cell Proliferation and Increase of Apoptosis through Regulation of the NF-κB and JNK Pathways by Silencing TRAF6 C-Domain mRNA.

Pleitrophin Is Highly Expressed by Myeloma Cells, Elevated in the Serum of Myeloma Patients, and Is a New Autocrine Growth Factor for This B Cell Malignancy.

Arsenic Trioxide Shows Synergistic Anti-Myeloma Effects When Combined with Bortezomib and Melphalan In Vitro and Helps Overcome Resistance of Multiple Myeloma Cells to These Treatments in Vivo.

Ascorbic Acid Overcomes Drug Resistance in Myeloma and Significantly Increases the Anti-Myeloma Effects of both Arsenic Trioxide and Melphalan in Vitro and in Vivo.

Pleitrophin Alone Induces Transdifferentiation of Human Monocytes and Bone Marrow Stem Cells into Endothelial Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only